Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome
Gallego-Escuredo, José M.
de Zegher, Francis
MetadataShow full item record
Background: Fetuin-A is a glycoprotein produced in the liver and related to metabolic syndrome; fetuin-A secretion is divergently regulated in different pathological conditions. In girls with polycystic ovary syndrome (PCOS), insulin sensitization results in a more favorable endocrine-metabolic outcome
than oral contraception; we assessed whether those differences are underscored by changes in circulating fetuin-A. Methods: Fetuin-A concentration endocrine-metabolic markers and hepatovisceral fat were measured longitudinally in 35 PCOS girls [age, 16 yr; body mass index (BMI), 23 kg/m2] randomized to receive either oral contraception [ethinylestradiol-levonorgestrel (n = 18)] or a low-dose combination of spironolactone, pioglitazone, and metformin (SPIOMET, n = 17) over 12 months. Healthy adolescent girls (age- and BMI-matched) were used as controls (n = 25). Results: Pretreatment fetuin-A serum levels in PCOS girls were lower than those in controls. After 12 months on treatment, fetuin-A raised to control levels only in the SPIOMET subgroup (P = 0.009, versus oral contraception); this increase was paralleled by a healthier metabolic profile with less hepatic fat (by MRI); baseline serum fetuin-A as well as the changes over 12 months was inversely related to hepatic adiposity. Conclusions: A low-dose combination of insulin sensitizers and an antiandrogen-but not oral contraception-normalizes fetuin-A levels in adolescent girls with PCOS. This trial is registered with ISRCTN29234515.
Is part ofInternational Journal of Endocrinology, 2018, núm. 4192940
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Reciprocal effects of antiretroviral drugs used to treat HIV infection on the fibroblast growth factor 21/β-Klotho System Moure, Ricardo; Domingo, Pere; Villarroya, Joan; Gasa, Laura; Gallego-Escuredo, José M.; Quesada-López, Tania; Morón-Ros, Samantha; Maroto, Alberto F.; Mateo, Gracia M.; Domingo, Joan C.; Villarroya, Francesc; Giralt, Marta (American Society for Microbiology, 2018)Following antiretroviral therapy, HIV-infected patients show increased circulating levels of the antidiabetic hormone fibroblast growth factor 21 (FGF21). In contrast, the expression of the FGF21-obligatory coreceptor ...
Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue Villarroya, Joan; Villarroya, Francesc; Gallego-Escuredo, José M.; Delgado‐Anglés, Alejando; Cairó, Montserrat; Moure, Ricardo; Mateo, Gracia M.; Domingo, Joan C.; Domingo, Pere; Giralt, Marta (Wiley Open Access, 2018)Fibroblast growth factor 21 (FGF21) has been proposed to be an antiaging hormone on the basis of experimental studies in rodent models. However, circulating FGF21 levels are increased with aging in rodents and humans. ...
Children and Adolescents Mental Health: A Systematic Review of Interaction-Based Interventions in Schools and Communities García Carrión, Rocío; Villarejo Carballido, Beatriz; Villardón Gallego, Lourdes (Frontiers Media, 2019-04-24)Background: There is growing evidence and awareness regarding the magnitude of mental health issues across the globe, starting half of those before the age of 14 and have lifelong effects on individuals and society. Despite ...